ProCE Banner Activity


A Paradigm Shift in Cervical Cancer: Putting New Options into Practice

PCE On Demand Live Presentation

Until recently, progress in the management of cervical cancer had been slow, resulting in a 5-year survival rate of just 16.5% for advanced/metastatic disease. Recent FDA approvals have led to a paradigm shift in treatment of this devastating disease, but the swift emergence of novel agents has meant that healthcare professionals may not be familiar with use of new therapies in clinical practice and the prevention and management of their associated toxicities. In this on-demand Webcast, gynecologic oncology experts present key evidence in support of novel treatments to manage advanced and recurrent cervical cancer, including discussion of patient cases and recommendations on managing adverse events (AEs) associated with novel therapies.

Physician Assistants: maximum of 1.00 hours of AAPA Category 1 CME credits Registered Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit

Released: May 19, 2022

Expiration: May 18, 2023

No longer available for credit.



Maria Avila-Wallace

Maria Avila-Wallace, NP

Nurse Practitioner
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Massachusetts General Hospital
Boston, Massachusetts

Grace Mbyirukira

Grace Mbyirukira, MPAS, PA-C

Physician Assistant
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Parkland Health and Hospital System
Dallas, Texas

Lauren Prescott

Lauren Prescott, MD, MPH

Assistant Professor, Obstetrics and Gynecology
Division of Gynecologic Oncology
Vanderbilt University Medical Center
Nashville, Tennessee


This activity is supported by an educational grant from Genmab and Seagen.

Provided by

ProCE Banner




Target Audience

Oncology NPs, PAs, and nurses

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Formulate evidence-based strategies for use of novel therapies in recurrent or metastatic cervical cancer

  • Identify AEs associated with novel agents for cervical cancer

  • Apply strategies to mitigate AEs associated with novel agents for cervical cancer, including appropriate patient counseling


All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Ms Avila-Wallace has no relevant financial relationships to disclose.

Ms Mbyirukira has no relevant financial relationships to disclose.

Dr Prescott: consultant: Tempus.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the evaluation form

The estimated time to complete this activity is 1.00 hour.

Release date: May 19, 2022
Expiration date: May 18, 2023


On-demand webcast


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.



Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until May 18, 2023. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.